4.5 Article

Catalytic domain of deubiquitinylase USP48 directs interaction with Rel homology domain of nuclear factor kappaB transcription factor RelA

Journal

MOLECULAR BIOLOGY REPORTS
Volume 46, Issue 1, Pages 1369-1375

Publisher

SPRINGER
DOI: 10.1007/s11033-019-04587-z

Keywords

Deubiquitinylase; NF-kappa B; Protein domains; RelA; Transcription factor; USP48

Funding

  1. Ministery of Economy, Science and Digitalisation (Forderung von Wissenschaft und Forschung in Sachsen-Anhalt aus Mitteln der Europaischen Struktur- und Investitionsfonds in der Forderperiode 2014-2020) [ZS/2016/04/78155]
  2. Medical Faculty of the Otto von Guericke University

Ask authors/readers for more resources

The activity and close regulation of nuclear factor kappaB (NF-kappa B) transcription factors is critical for a variety of cellular processes including inflammation, immunity, differentiation and cell survival. Thus, dysregulation of the NF-kappa B system could lead to serious diseases, e.g. uncoordinated growth of the normal tissue during the development of cancer. Transcriptional activity of the NF-kappa B factor RelA is regulated by a number of mechanisms which comprise ubiquitinylation by a multimeric ubiquitin ligase containing Elongins B and C, cullin-2 (Cul2) and suppressor of cytokine signaling 1 (SOCS1), but also USP48-dependent deubiquitinylation. Further, USP48 promotes cell survival and antagonizes also other E3 ligase functions which are involved in genome stability and DNA repair. The regulation of RelA by USP48 has been investigated in detail, but the domains of USP48 and RelA for direct interaction are not known. In this study we report that USP48 interacts physically with RelA in the nucleus. Further, we show by overexpression of truncated proteins that the catalytic USP domain of USP48 interacts with the N-terminal region of the Rel homology domain (RHD) of RelA. This study provides first evidence that the USP domain of USP48 is important for the physical association with substrate proteins, and a suitable target for small molecule inhibitors for therapeutic intervention strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available